CIGB-552

N/A

Report date: 2023/02/11 20:37:40
NME

Base Information

Drug NameCIGB-552
Drug Alias NameCIGB-552
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionApoptosis stimulantsCOMM domain-containing protein 1 stimulants
TargetsCOMM domain-containing protein 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCenter For Genetic Engineering And Biotechnology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHeber BiotecCenter For Genetic Engineering And Biotechnology
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A